SGRY has 36-month beta value of 2.63. Analysts have mixed views on the stock, with 8 analysts rating it as a “buy,” 2 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for SGRY is 73.98M, and currently, short sellers hold a 13.73% ratio of that float. The average trading volume of SGRY on November 19, 2024 was 908.82K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SGRY) stock’s latest price update
Surgery Partners Inc (NASDAQ: SGRY) has experienced a rise in its stock price by 3.14 compared to its previous closing price of 21.83. However, the company has seen a fall of -23.85% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty – Chief Financial Officer Wayne DeVeydt – Executive Chairman Eric Evans – Chief Executive Officer Conference Call Participants Jack Slevin – Jefferies Joanna Gajuk – Bank of America A.J. Rice – UBS Andrew Mok – Barclays Tao Qiu – Stifel Sarah James – Cantor Fitzgerald Bill Sutherland – The Benchmark Company Benjamin Rossi – JPMorgan Will Spivack – TD Cowen Operator Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call.
SGRY’s Market Performance
SGRY’s stock has fallen by -23.85% in the past week, with a monthly drop of -29.37% and a quarterly drop of -19.38%. The volatility ratio for the week is 10.34% while the volatility levels for the last 30 days are 5.31% for Surgery Partners Inc The simple moving average for the past 20 days is -20.48% for SGRY’s stock, with a -21.27% simple moving average for the past 200 days.
Analysts’ Opinion of SGRY
Many brokerage firms have already submitted their reports for SGRY stocks, with UBS repeating the rating for SGRY by listing it as a “Buy.” The predicted price for SGRY in the upcoming period, according to UBS is $38 based on the research report published on October 14, 2024 of the current year 2024.
Macquarie gave a rating of “Outperform” to SGRY, setting the target price at $31 in the report published on June 28th of the current year.
SGRY Trading at -25.70% from the 50-Day Moving Average
After a stumble in the market that brought SGRY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.00% of loss for the given period.
Volatility was left at 5.31%, however, over the last 30 days, the volatility rate increased by 10.34%, as shares sank -28.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.34% lower at present.
During the last 5 trading sessions, SGRY fell by -23.82%, which changed the moving average for the period of 200-days by -29.68% in comparison to the 20-day moving average, which settled at $28.32. In addition, Surgery Partners Inc saw -29.61% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SGRY starting from Bradley Owens, who proposed sale 9,241 shares at the price of $30.69 back on Sep 05 ’24. After this action, Bradley Owens now owns shares of Surgery Partners Inc, valued at $283,652 using the latest closing price.
Bane Harrison R., the National Group President of Surgery Partners Inc, sale 6,325 shares at $31.11 during a trade that took place back on Sep 04 ’24, which means that Bane Harrison R. is holding 48,236 shares at $196,742 based on the most recent closing price.
Stock Fundamentals for SGRY
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.21 for the gross margin
The net margin for Surgery Partners Inc stands at -0.02. The total capital return value is set at 0.05. Equity return is now at value -3.11, with -0.85 for asset returns.
Based on Surgery Partners Inc (SGRY), the company’s capital structure generated 0.65 points at debt to capital in total, while cash flow to debt ratio is standing at 0.07. The debt to equity ratio resting at 1.83. The interest coverage ratio of the stock is 1.8.
Currently, EBITDA for the company is 446.1 million with net debt to EBITDA at 6.35. When we switch over and look at the enterprise to sales, we see a ratio of 2.06. The receivables turnover for the company is 5.5for trailing twelve months and the total asset turnover is 0.4. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
To put it simply, Surgery Partners Inc (SGRY) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
